CIK 0001386570
- Large accelerated filer
Niagen Bioscience, Inc.
Sign in to watch- Ticker
- NAGE
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262940963
- Phone
- +1 310-388-6706
- Business address
- 10900 WILSHIRE BLVD, SUITE 600, LOS ANGELES, CA, 90024
- Former names
- ChromaDex Corp., CODY RESOURCES, INC.
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy CEO bought 10,000 shares at $3.09 ($30,900)
- 4 Open-market buy CEO bought 2,500 shares at $4.03 ($10,075)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO bought 2,253 shares at $4.43 ($9,981)
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 6,900 shares at $3.85 ($26,565)
- 4 Open-market buy CEO bought 5,000 shares at $3.80 ($19,000)
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 6,725 shares at $3.99 ($26,833)
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 7,300 shares at $3.62 ($26,426)
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 5,700 shares at $3.49 ($19,893)
- 4 Open-market sale EXECUTIVE CHAIRMAN OF BOARD sold 14,390 shares at $3.50 ($50,365)
- 4 Open-market sale Director sold 10,000 shares at $3.52 ($35,200)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 20 · 384 filings